Artificial intelligence and machine learning are transforming the medical device industry. Simultaneously, companies are working to gain Food and Drug Administration approval and obtain intellectual property protection for...more
On April 10, 2024, the United States Patent and Trade Office (USPTO) announced guidance regarding the use of artificial intelligence (AI) tools before the USPTO. ...more
A recent article, “Discovering Value: Women’s Participation in University and Commercial Artificial Intelligence (AI) Invention,” reports on a new study finding that women’s participation in patenting results in patents with...more
Patent Center Replaces EFS-Web and Private PAIR -
On November 15, following a one-week delay, the legacy EFS-Web and Private Patent Application Information Retrieval (Private PAIR) systems were officially retired and...more
USPTO News -
On October 23, 2023, the USPTO Office of the Chief Economist released a report detailing patenting activity related to COVID-19 diagnostic technology....more
11/6/2023
/ Artificial Intelligence ,
Biden Administration ,
Consultation ,
Coronavirus/COVID-19 ,
Diagnostic Tests ,
Executive Orders ,
Information Reports ,
Intellectual Property Protection ,
Patent Trial and Appeal Board ,
Patents ,
Tribal Governments ,
WIPO